middl
east
respiratori
syndrom
mer
caus
merscoronaviru
merscov
emerg
respiratori
diseas
global
public
health
concern
high
mortal
rate
may
busi
travel
republ
korea
identifi
first
import
case
merscov
infect
china
world
health
organ
receiv
notif
confirm
case
merscov
infect
republ
korea
mid
may
notifi
later
one
close
contact
index
mer
case
republ
korea
travel
guangdong
provinc
china
way
hong
kong
first
merscov
case
china
import
republ
korea
confirm
nation
health
famili
commiss
peopl
republ
china
may
patient
admit
huizhou
municip
central
hospit
huizhou
guangdong
provinc
may
discharg
recoveri
june
set
venou
blood
sampl
collect
admiss
confirm
specif
inactiv
merscov
virionbas
elisa
background
normal
sera
anti
merscov
igm
igg
sera
newborn
sera
normal
healthi
adult
detect
elisa
evalu
serolog
respons
mer
patient
discharg
risk
transmiss
set
serum
sampl
patient
pair
serum
sampl
collect
least
apart
close
contact
mer
patient
trip
hospit
admiss
china
test
merscov
use
inactiv
merscovbas
elisa
meanwhil
confirm
specif
sensit
inactiv
merscovbas
elisa
commerci
avail
euroimmun
ag
germani
merscov
elisa
perform
refer
assay
includ
calibr
defin
upper
limit
refer
rang
noninfect
person
cutoff
recommend
euroimmun
valu
indic
cutoff
consid
posit
neg
mersspik
pseudoparticl
neutral
test
ppnt
base
envdefect
report
gene
luciferaseexpress
genom
perform
previoiusli
describ
neutral
antibodi
titer
defin
highest
serum
dilut
result
reduct
rel
luciferas
unit
strengthen
infect
control
measur
identifi
possibl
persontoperson
transmiss
close
contact
mer
patient
also
sampl
total
close
contact
mer
case
journey
identifi
monitor
isol
last
contact
mer
case
includ
hotel
staff
compani
employe
restaur
waiter
bu
passeng
plane
passeng
close
contact
includ
facetofac
contact
patient
well
distant
contact
none
present
symptom
compat
mer
throat
swab
sampl
close
contact
neg
merscov
realtim
rtpcr
pair
serum
sampl
final
avail
close
contact
pair
serum
sampl
close
contact
merscov
patient
collect
day
apart
june
blood
sampl
process
within
h
collect
sera
store
serum
sampl
close
contact
test
neg
merscov
real
time
rtpcr
use
inactiv
merscov
particlebas
elisa
analyz
serum
sampl
import
merscov
patient
close
contact
presenc
igg
merscov
experi
involv
live
merscov
conduct
accord
standard
oper
procedur
biosafeti
level
facil
chines
center
diseas
control
prevent
normal
control
compris
serum
sampl
healthi
blood
donor
use
determin
background
valu
calcul
cutoff
level
anti
merscov
igm
igg
sera
newborn
normal
control
sera
detect
dilut
elisa
averag
valu
newborn
normal
adult
control
x
calcul
rang
rang
igm
differ
exist
two
group
ttest
p
rang
rang
serum
igg
differ
exist
two
group
ttest
p
figur
cutoff
valu
determin
x
ie
igm
igg
antimerscov
titer
determin
serial
serum
sampl
mer
patient
serum
igm
igg
level
day
follow
admiss
may
markedli
lower
cutoff
valu
exceed
cutoff
valu
admiss
plateau
day
admiss
figur
serum
igm
igg
titer
increas
immedi
discharg
june
figur
igg
titer
patient
shortli
admiss
compar
higher
higher
discharg
data
shown
demonstr
merscov
seroconvers
mer
elisa
result
show
valu
calibr
recommend
euroimmun
defin
cutoff
valu
consequ
antim
mer
patient
exceed
cutoff
valu
day
admiss
figur
consist
result
report
guan
et
al
although
seroconvers
antimerscov
igg
appear
two
day
earlier
inactiv
merscov
similar
antibodi
kinet
base
mer
inactiv
merscov
appear
high
correl
coeffieient
figur
lentivirusbas
merscov
pseudoviru
neutral
test
perform
confirm
presenc
merscovspecif
antibodi
serum
sampl
patient
neutral
antibodi
titer
test
day
admiss
peak
admiss
figur
result
neutral
test
correl
well
elisa
result
pair
serum
sampl
close
contact
cutoff
valu
neg
merscov
elisa
figur
averag
valu
serum
sampl
collect
june
respect
seroconvers
detect
close
contact
lentivirusbas
merscov
pseudoviru
preincub
serial
dilut
sera
import
merscov
patient
h
addit
cell
h
incub
fresh
medium
ad
cultur
follow
incub
h
cell
wash
pb
lyse
use
lysi
reagent
includ
luciferas
kit
promega
aliquot
cell
lysat
transfer
costar
flatbottom
luminomet
plate
corn
costar
follow
addit
luciferas
substrat
promega
rfi
valu
determin
immedi
use
gaomax
luminomet
promega
rfi
reduct
use
calcul
merscovspecif
neutral
antibodi
titer
serum
sampl
fiftythre
pair
serum
sampl
close
contact
may
expos
import
merscov
patient
collect
interv
least
sera
dilut
subject
inactiv
merscovbas
elisa
hrplabel
goat
antihuman
igg
use
secondari
antibodi
tmb
substrat
absorb
read
nm
valu
higher
cutoff
valu
consid
indic
merscov
posit
korean
outbreak
show
merscov
result
epidem
despit
lack
appar
mutat
thu
repres
global
threat
public
health
mani
laboratori
testssuch
immunofluoresc
assay
elisa
microneutr
assay
realtim
rtpcr
assayshav
use
confirm
merscov
infect
mer
patient
close
contact
howev
data
regard
dynam
antimerscov
igg
merscov
neutral
antibodi
lack
studi
develop
method
detect
antibodi
merscov
use
inactiv
merscov
particlebas
indirect
enzymelink
immunosorb
assay
elisa
lentivirusbas
merscov
pseudoviru
assay
serum
antimerscov
igg
level
mer
patient
immedi
improv
discharg
demonstr
seroconvers
serum
igm
igg
level
reach
plateau
admiss
determin
kinet
merscov
neutral
antibodi
titer
highest
approxim
admiss
agreement
igg
curv
declin
gradual
approxim
discharg
south
korea
experienc
mer
outbreak
repres
largest
cluster
mer
case
outsid
middl
east
octob
case
includ
mer
case
export
china
merscov
infect
associ
south
korea
outbreak
die
sever
report
household
nosocomi
transmiss
merscov
healthcar
worker
hospit
merscov
patient
andor
delay
implement
effect
infect
control
practic
import
merscov
patient
china
admit
june
suffer
high
fever
realtim
rtpcr
indic
high
viral
load
serum
throat
swab
sampl
seroconvers
often
occur
exposur
perform
serolog
detect
pair
serum
sampl
minim
possibl
miss
asymptomat
infect
howev
none
close
contact
posit
merscov
suggest
none
commun
transmiss
merscov
occur
china
lack
transmiss
merscov
patient
close
contact
studi
may
due
sever
factor
short
durat
exposur
importantli
implement
china
strict
infect
prevent
control
practic
immedi
notifi
import
merscov
patient
find
similar
result
investig
healthcar
worker
follow
import
first
mer
case
usa
conclus
first
determin
kinet
antibodi
igg
igm
neutral
antibodi
merscov
first
import
mer
case
china
data
close
contact
investig
indic
abil
limit
humantohuman
transmiss
merscov
howev
everi
year
approxim
resid
china
travel
return
mecca
saudi
arabia
ramadan
period
travelassoci
import
transmiss
merscov
remain
possibl
prevent
merscov
infect
earli
screen
routin
supervis
requir
especi
confirm
suspect
mer
case
close
contact
thereof
